1179 related articles for article (PubMed ID: 34793124)
1. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Qiu M; Li Y; Bloomer H; Xu Q
Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
[TBL] [Abstract][Full Text] [Related]
3. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
[TBL] [Abstract][Full Text] [Related]
4. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
8. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids.
Sato Y
Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281
[TBL] [Abstract][Full Text] [Related]
9. Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases.
Vadovics M; Muramatsu H; Sárközy A; Pardi N
Methods Mol Biol; 2024; 2786():167-181. PubMed ID: 38814394
[TBL] [Abstract][Full Text] [Related]
10. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
[TBL] [Abstract][Full Text] [Related]
11. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
Cui L; Hunter MR; Sonzini S; Pereira S; Romanelli SM; Liu K; Li W; Liang L; Yang B; Mahmoudi N; Desai AS
Small; 2022 Mar; 18(9):e2105832. PubMed ID: 34914866
[TBL] [Abstract][Full Text] [Related]
13. mRNA delivery technologies: Toward clinical translation.
Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
[TBL] [Abstract][Full Text] [Related]
14. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
[TBL] [Abstract][Full Text] [Related]
15. Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA.
Jung O; Jung HY; Thuy LT; Choi M; Kim S; Jeon HG; Yang J; Kim SM; Kim TD; Lee E; Kim Y; Choi JS
Adv Healthc Mater; 2024 Feb; ():e2303857. PubMed ID: 38344923
[TBL] [Abstract][Full Text] [Related]
16. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
[TBL] [Abstract][Full Text] [Related]
17. Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Billingsley MM; Singh N; Ravikumar P; Zhang R; June CH; Mitchell MJ
Nano Lett; 2020 Mar; 20(3):1578-1589. PubMed ID: 31951421
[TBL] [Abstract][Full Text] [Related]
18. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
[TBL] [Abstract][Full Text] [Related]
19. Non-liver mRNA Delivery.
Loughrey D; Dahlman JE
Acc Chem Res; 2022 Jan; 55(1):13-23. PubMed ID: 34859663
[TBL] [Abstract][Full Text] [Related]
20. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
Tenchov R; Bird R; Curtze AE; Zhou Q
ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
